Shen Lian Biomedical wins veterinary vaccine approval
Shanghai Shen Lian Biomedical Corporation announced approval of its "Inactivated Avian Adenovirus (Group I, Type 4) Vaccine (DN Strain)" as a new veterinary drug, developed jointly with Guizhou Foster Biotechnology Co., Ltd.
The vaccine prevents avian adenovirus disease in poultry, with immunity developing within 21 days and lasting four to six months depending on chicken age. It requires subcutaneous or intramuscular injection.
The approval is expected to expand the company's product portfolio and boost sales, though a product approval number is still required before commercial sale can begin.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Shanghai Shen Lian Biomedical Corporation publishes news
Free account required • Unsubscribe anytime